Tamarind Bio
PrivateLast Round
Series A
Feb 26, 2026
Total Funding Raised
$27.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tamarind Bio is a biotechnology company that develops a no-code computational platform and API for drug discovery, enabling researchers to deploy and run bioinformatics models without managing complex infrastructure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Workflow Automation, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tamarind Bio Comparables
Compare Tamarind Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LatchBio | 85% | |
| Pluto Biosciences | 82% | |
| Benchling | 79% |
Tamarind Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2026 | ||||
| Series A | May 15, 2025 | ||||
| Seed | Jan 1, 2024 |
Key People
Founding team and executive leadership
Tamarind Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dimension | Series A |
| Treeo VC | Series A |
| Phosphor Capital | Series A |
| Y Combinator | Seed, Series A |
| Dimensional Fund Advisors | Series A |
| 468 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jul 30, 2026
Grew 62% QoQ, from 13 to 21 employees.
Recent news
Latest coverage and updates
- integrates_withAug 5, 2026
Tamarind integrated with GenScript Biotech Corp. on Aug 5th '26.
- is_developingAug 5, 2026
Tamarind is developing connected validation engine for AI-enabled discovery on Aug 5th '26.
Tamarind Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tamarind Bio's valuation, stock price, and market status.
Is Tamarind Bio a public or private company?
Tamarind Bio is a private company.
What is the current stock price of Tamarind Bio?
Tamarind Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Tamarind Bio worth (valuation)?
Valuation information for Tamarind Bio is not publicly available.
Can I buy Tamarind Bio stock?
Tamarind Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tamarind Bio's last funding round?
Tamarind Bio's most recent funding round was Series A on February 26, 2026.
Who are the main investors in Tamarind Bio?
Key investors in Tamarind Bio include Dimension, Dimension.
Will Tamarind Bio IPO soon?
No public IPO plans have been announced for Tamarind Bio.
How can I track Tamarind Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tamarind Bio's secondary market activity and sign up for updates.